Shintakuya, R.; Uemura, K.; Sumiyoshi, T.; Okada, K.; Baba, K.; Harada, T.; Murakami, Y.; Serikawa, M.; Ishii, Y.; Arihiro, K.;
et al. Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms. J. Clin. Med. 2023, 12, 6778.
https://doi.org/10.3390/jcm12216778
AMA Style
Shintakuya R, Uemura K, Sumiyoshi T, Okada K, Baba K, Harada T, Murakami Y, Serikawa M, Ishii Y, Arihiro K,
et al. Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine. 2023; 12(21):6778.
https://doi.org/10.3390/jcm12216778
Chicago/Turabian Style
Shintakuya, Ryuta, Kenichiro Uemura, Tatsuaki Sumiyoshi, Kenjiro Okada, Kenta Baba, Takumi Harada, Yoshiaki Murakami, Masahiro Serikawa, Yasutaka Ishii, Koji Arihiro,
and et al. 2023. "Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms" Journal of Clinical Medicine 12, no. 21: 6778.
https://doi.org/10.3390/jcm12216778
APA Style
Shintakuya, R., Uemura, K., Sumiyoshi, T., Okada, K., Baba, K., Harada, T., Murakami, Y., Serikawa, M., Ishii, Y., Arihiro, K., & Takahashi, S.
(2023). Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine, 12(21), 6778.
https://doi.org/10.3390/jcm12216778
